Abstract
Stressful life events and dysfunctional Hypothalamic Pituitary Adrenal (HPA) axis have been implicated in the pathogenesis of psychiatric disorders, including anxiety disorders.
This paper attempts to review the existing literature on childhood traumata, recent life events, HPA axis functioning and their relationship in Post-Traumatic Stress Disorder, Panic Disorder, Generalized Anxiety Disorder, Obsessive Compulsive Disorder and Social Phobia. Preclinical and clinical models will be analyzed. Stressful life events seem to have a role in the onset and in the course of these disorders and HPA axis abnormalities have been reported in almost all anxiety disorders. The hypothesis that early stressful life events may provoke alterations of the stress response and thus of the HPA axis, that can endure during adulthood, predisposing individuals to develop psychopathology, will be evaluated.Keywords: Animal models, anxiety disorders, childhood traumata, cortisol, Hypothalamic Pituitary Adrenal axis, life events, stress response, vulnerability.
Current Pharmaceutical Design
Title:The Role of Life Events and HPA Axis in Anxiety Disorders: A Review
Volume: 18 Issue: 35
Author(s): Carlo Faravelli, Carolina Lo Sauro, Lorenzo Lelli, Francesco Pietrini, Lisa Lazzeretti, Lucia Godini, Laura Benni, Giulia Fioravanti, Gabriela Alina Talamba, Giovanni Castellini and Valdo Ricca
Affiliation:
Keywords: Animal models, anxiety disorders, childhood traumata, cortisol, Hypothalamic Pituitary Adrenal axis, life events, stress response, vulnerability.
Abstract: Stressful life events and dysfunctional Hypothalamic Pituitary Adrenal (HPA) axis have been implicated in the pathogenesis of psychiatric disorders, including anxiety disorders.
This paper attempts to review the existing literature on childhood traumata, recent life events, HPA axis functioning and their relationship in Post-Traumatic Stress Disorder, Panic Disorder, Generalized Anxiety Disorder, Obsessive Compulsive Disorder and Social Phobia. Preclinical and clinical models will be analyzed. Stressful life events seem to have a role in the onset and in the course of these disorders and HPA axis abnormalities have been reported in almost all anxiety disorders. The hypothesis that early stressful life events may provoke alterations of the stress response and thus of the HPA axis, that can endure during adulthood, predisposing individuals to develop psychopathology, will be evaluated.Export Options
About this article
Cite this article as:
Faravelli Carlo, Lo Sauro Carolina, Lelli Lorenzo, Pietrini Francesco, Lazzeretti Lisa, Godini Lucia, Benni Laura, Fioravanti Giulia, Alina Talamba Gabriela, Castellini Giovanni and Ricca Valdo, The Role of Life Events and HPA Axis in Anxiety Disorders: A Review, Current Pharmaceutical Design 2012; 18 (35) . https://dx.doi.org/10.2174/138161212803530907
DOI https://dx.doi.org/10.2174/138161212803530907 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Neuroprotection by vitamin C against ethanol -induced neuroinflammation associated neurodegeneration in developing rat brain
CNS & Neurological Disorders - Drug Targets Macrophage-Assisted Inflammation and Pharmacological Regulation of the Cholinergic Anti-Inflammatory Pathway
Current Medicinal Chemistry Contribution of Recent Transgenic Models and Transcriptional Profiling Studies to Our Understanding of the Mechanisms by which Androgens Control Spermatogenesis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Renin-Angiotensin Systems: Evolving Pharmacological Perspectives for Cerebroprotection
Current Pharmaceutical Design Advances in Antioxidative Therapy of Multiple Sclerosis
Current Medicinal Chemistry Proteases Essential for Human Influenza Virus Entry into Cells and Their Inhibitors as Potential Therapeutic Agents
Current Pharmaceutical Design Molecular Imaging Aided Improvement in Drug Discovery and Development
Current Biotechnology Neuropeptide Y: Role in Emotion and Alcohol Dependence
CNS & Neurological Disorders - Drug Targets A Systematic Review of Plant-Derived Natural Compounds for Anxiety Disorders
Current Topics in Medicinal Chemistry Melanocortins and their Receptors and Antagonists
Current Drug Targets Phosphatidylserine and Curcumin Act Synergistically to Down-Regulate Release of Interleukin-1β from Lipopolysaccharide-Stimulated Cortical Primary Microglial Cells
CNS & Neurological Disorders - Drug Targets Why Do We Need New Markers for Male Hypogonadism and How Seminal Proteomics Might Solve the Problem?
Protein & Peptide Letters Control of Menopausal Transition through Physical Exercises
Current Women`s Health Reviews Current & Future Therapies of Erectile Dysfunction in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued) Safety and Side Effects of Cannabidiol, a Cannabis sativa Constituent
Current Drug Safety The GABAA-BZR Complex as Target for the Development of Anxiolytic Drugs
Current Topics in Medicinal Chemistry Pharmacokinetics and Systemic Activity of a New Patent of an Inhaled Corticosteroid/Long-Acting β2-Agonist Combination for Use in Asthma Therapy: Fluticasone Furoate/Vilanterol Trifenatate
Recent Patents on Inflammation & Allergy Drug Discovery Increased Salt Sensitivity in Obese Hypertension: Role of the Sympathetic Nervous System
Current Hypertension Reviews Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment
Current Vascular Pharmacology Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry